Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

被引：0

作者：

Paller, Amy S. ^{[1
]}

Yosipovitch, Gil ^{[2
]}

Tom, Wynnis L. ^{[3
,4
]}

Lebwohl, Mark ^{[5
]}

Boguniewicz, Mark ^{[6
,7
]}

Call, Robert S. ^{[8
]}

Eichenfield, Lawrence F. ^{[3
,4
]}

Forsha, Douglass W. ^{[9
]}

Rees, William C. ^{[10
]}

Simpson, Eric L. ^{[11
]}

Gold, Linda F. Stein ^{[12
]}

Zaenglein, Andrea L. ^{[13
]}

Tallman, Anna M. ^{[14
]}

Tan, Bill ^{[14
]}

Hebert, Adelaide A. ^{[15
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[3] Rady Childrens Hosp San Diego, San Diego, CA USA

[4] Univ Calif San Diego, San Diego, CA 92103 USA

[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[6] Natl Jewish Hlth, Denver, CO USA

[7] Univ Colorado, Sch Med, Denver, CO USA

[8] Clin Res Partners, Richmond, VA USA

[9] Jordan Valley Dermatol & Res Ctr, W Jordan, UT USA

[10] PI Coor Clin Res, Burke, VA USA

[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[12] Henry Ford Hlth Syst, Detroit, MI USA

[13] Penn State Univ, Hershey, PA USA

[14] Pfizer Inc, New York, NY USA

[15] Univ Texas Houston, Med Ctr, Houston, TX USA

来源：

PEDIATRICS | 2018年 / 142卷

关键词：

D O I：

10.1542/peds.142.1_MeetingAbstract.815

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

815

引用

页数：2

共 50 条

[31] Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials
Del Rosso, James Q.
Gold, Linda Stein
Baldwin, Hilary
Harper, Julie C.
Zeichner, Joshua
Obagi, Sabine
Graber, Emmy
Jimenez, Xochitl
Vicente, Francisco Hernandez
Grada, Ayman
JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (06) : 634 - 640
[32] Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials
de Bruin-Weller, Marjolein
Simpson, Eric L.
Cork, Michael
Chen, Zhen
Msihid, Jerome
Taniou, Christine
Eckert, Laurent
Gadkari, Abhijit
Bego-Le Bagousse, Gaelle
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1499 - 1501
[33] Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2)
Simpson, E. L.
Bieber, T.
Guttman-Yassky, E.
Beck, L. A.
Blauvelt, A.
Cork, M. J.
Silverberg, J. I.
Deleuran, M.
Kataoka, Y.
Lacour, J. -P.
Kingo, K.
Worm, M.
Poulin, Y.
Wollenberg, A.
Soo, Y.
Graham, N. M. H.
Pirozzi, G.
Akinlade, B.
Staudinger, H.
Mastey, V.
Eckert, L.
Gadkari, A.
Ardeleanu, M.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 79 - 79
[34] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
Tofte, Susan J.
Papp, Kim
Sadick, Neil
Bohnert, Krista
Simpson, Eric
Thaci, Diamant
Bieber, Thomas
Blauvelt, Andrew
Sofen, Howard
Gooderham, Melinda
Chen, Zhen
Gadkari, Abhijit
Eckert, Laurent
Graham, Neil M. H.
Pirozzi, Gianluca
Ardeleanu, Marius
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09): : 529 - 541
[35] Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor
Zane, Lee Thomas
Paller, Amy S.
Tom, Wynnis L.
Lebwohl, Mark G.
Blumenthal, Robin L.
Boguniewicz, Mark
Call, Robert S.
Eichenfield, Lawrence F.
Forsha, Douglass W.
Rees, William C.
Simpson, Eric L.
Gold, Linda F. Stein
Zaenglein, Andrea L.
Hebert, Adelaide A.
JOURNAL OF IMMUNOLOGY, 2016, 196
[36] Effect of Dupilumab on Global Individual Signs Score Outcomes in Adults With Moderate-to-Severe Atopic Dermatitis: Combined Results From Four Phase 3 Trials
Staubach-Renz, P.
Silverberg, J.
de Bruin-Weller, M.
Irvine, A. D.
Ardeleanu, M.
Chen, Z.
Clibborn, C.
Sorrentino, A.
Rossi, A. B.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S244 - S244
[37] Efficacy of ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies
Blauvelt, Andrew
Eichenfield, Lawrence F.
Kuligowski, Michael E.
Venturanza, May E.
Sun, Kang
Silverberg, Jonathan I.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB148 - AB148
[38] A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitis
Paller, A. S.
Tom, W. L.
Call, R. S.
Eichenfield, L.
Forsha, D.
Rees, W.
Spellman, M.
Zane, L. T.
Hebert, A. A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S166 - S166
[39] Effect of BMI on Baricitinib Efficacy: Pooled Analysis from Two Phase 3 Rheumatoid Arthritis Clinical Trials
Zerbini, Cristiano A. F.
Muram, David
Arora, Vipin K.
Alam, Jahangir
Curtis, Jeffrey R.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[40] Peak Pruritus Numeric Rating Scale response with abrocitinib in patients with moderate to severe atopic dermatitis: Results from a randomized phase 3 clinical trial
Simpson, Eric L.
Staender, Sonja
Yosipovitch, Gil
Cameron, Michael C.
DiBonaventura, Marco
Williams, David
Tatulych, Svitlana
Nduaka, Chudy
Valdez, Hernan
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB61 - AB61

← 1 2 3 4 5 →